Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.
about
Patient perceptions of quality of life with diabetes-related complications and treatmentsVariation in diabetes care by age: opportunities for customization of careEconomics of Team-based Care in Controlling Blood Pressure: A Community Guide Systematic ReviewThe incremental costs of recommended therapy versus real world therapy in type 2 diabetes patientsDevelopment of an economic evaluation of diagnostic strategies: the case of monogenic diabetesGetReal in mathematical modelling: a review of studies predicting drug effectiveness in the real world.Effect of advanced access scheduling on processes and intermediate outcomes of diabetes care and utilization.Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery deviceCommentary on the United Kingdom Prospective Diabetes Study outcomes model 2: Need for long-term follow up and quality of life data in Asian patients.Clinical outcomes and adherence to medications measured by claims data in patients with diabetesIndirect estimation of a discrete-state discrete-time model using secondary data analysis of regression data.A successful chronic care program in Al Ain-United Arab Emirates.Costs and consequences associated with newer medications for glycemic control in type 2 diabetes.Economic evaluation of sirolimus-eluting stents.The effect of Medicare Part D on drug and medical spending.Cost-effectiveness of aspirin use among persons with newly diagnosed type 2 diabetes.The cost-effectiveness of continuous glucose monitoring in type 1 diabetes.Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) .Community-based participatory research and user-centered design in a diabetes medication information and decision toolCost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review.2010 Canadian Hypertension Education Program recommendations: An annual update.Cost-effectiveness of bariatric surgery for severely obese adults with diabetes.Chronic disease modeling and simulation software.Cost-effectiveness of health-related lifestyle advice delivered by peer or lay advisors: synthesis of evidence from a systematic reviewAgency social workers could monitor hypertension in the communityWithin-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.The impact of diabetes on workforce participation: results from a national household sample.A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitusEffect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial.Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes.Near-Normalization of Glucose and Microvascular Diabetes Complications: Data from ACCORD and ADVANCE.The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes.Are physical activity interventions in primary care and the community cost-effective? A systematic review of the evidence.Diabetic patients who smoke: are they different?Characteristics of insured patients with persistent gaps in diabetes care services: the Translating Research into Action for Diabetes (TRIAD) study.When there is too much to do: how practicing physicians prioritize among recommended interventions.Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factorsPreliminary development of a clinical decision rule for acute aortic syndromesEffect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus.Improved self-management skills in Chinese diabetes patients through a comprehensive health literacy strategy: study protocol of a cluster randomized controlled trial.
P2860
Q24644699-C5A6D997-E446-4528-88C0-72E95907C0CCQ24797542-F07818BF-6043-49B5-81D1-0342B3007926Q28083249-C91E917F-8FA6-4161-A35D-20029B90922FQ28201491-63D954A9-1A1A-43C5-BFE6-D36B78CB1FF2Q28689671-E376959A-7F77-4992-91C1-43091EDB61EDQ30248472-0320459F-EC22-49A4-A9E8-83B43C5BA931Q30484030-5C036256-F826-4A54-8BDE-6406C6AEF476Q30671559-AF82B52B-41D9-4666-9E45-354D30A928BDQ30824528-41DF25D0-46EA-49BD-88FB-7BEA4F8944C6Q30977056-481A1247-F0BB-4DC5-8579-425E88A57B17Q33448660-35EAA2F9-F571-4A35-971A-695456557D53Q33533481-64A2D1B1-2C39-490B-9DE4-88938E2D3D2EQ33751401-FFB312AB-CA14-4712-9AB3-E9F4B5DFFA71Q33759433-F38A3825-0BB6-4D58-A4E5-D9822627D647Q33810332-83CB2CEC-CD87-4CF9-8813-DC0D0549EAC8Q33873025-58701982-011A-47AA-9C50-02C2C073C7CCQ33873097-F689291C-A3DF-429C-912A-4F2004452B4AQ33913848-94314142-5F00-4172-A5BF-F5ACCDDF9CC2Q33981486-ED71CDFD-55A7-4056-9C70-464307BA9DDCQ34016162-B823A093-9AA1-40FC-B6DA-8606698AF147Q34066861-53F5F8F6-0FDB-4445-A0BA-E3E8083F67F4Q34084468-3C8071CF-855B-4693-84F5-C01BA8A35CB1Q34108081-1AC6D7F3-1529-4A0F-A7DE-9C012B8D1D51Q34245935-C830DAC4-9DB4-4E91-BE96-1F3D15DB211CQ34247990-521E0DC5-411C-4FA9-BDE4-9D9F7F5517D8Q34335538-77F54941-6651-4056-BF22-A9F92C14B2D2Q34336889-33E6B735-F400-4473-B9EC-C7D036D3D868Q34398616-15D782D6-8692-49CB-BBF8-671C456EF0AAQ34422037-7A8AD9F4-63BC-422A-B530-562E59C226E1Q34453963-D8B57620-2CD2-49AA-9DEF-658C318A60CFQ34475442-907435BC-DACC-46CF-AFDB-8B97A5B563A9Q34583285-57F201E6-008F-4E6E-A58F-43E1FBC9309DQ34617694-CFA99838-2573-4644-A031-F47E0F89DD02Q34628302-03B78A13-6C73-4D35-8E27-9B56D7A5A316Q34724785-21085995-9F5E-4D44-9538-B758CA7C4D0FQ34732958-3078302B-3F18-420D-9F24-C4F60F2E3798Q34733821-A940D09A-2F10-4465-8186-B3B724D4BE2EQ34768433-D9C1C02E-5133-4E90-A72F-A699729AC932Q34988073-48A78CB7-854B-470F-A104-08CFBE45C2A5Q35018017-89250857-905E-411A-87A7-71097199BC68
P2860
Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Cost-effectiveness of intensiv ...... reduction for type 2 diabetes.
@en
Cost-effectiveness of intensiv ...... reduction for type 2 diabetes.
@nl
type
label
Cost-effectiveness of intensiv ...... reduction for type 2 diabetes.
@en
Cost-effectiveness of intensiv ...... reduction for type 2 diabetes.
@nl
prefLabel
Cost-effectiveness of intensiv ...... reduction for type 2 diabetes.
@en
Cost-effectiveness of intensiv ...... reduction for type 2 diabetes.
@nl
P356
P1476
Cost-effectiveness of intensiv ...... reduction for type 2 diabetes.
@en
P2093
CDC Diabetes Cost-effectiveness Group
P304
P356
10.1001/JAMA.287.19.2542
P407
P577
2002-05-01T00:00:00Z